# Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck Malignancies

> **NCT00266279** · PHASE2 · COMPLETED · sponsor: **University of Louisville** · enrollment: 17 (actual)

## Conditions studied

- Head or Neck Cancer

## Interventions

- **DRUG:** Oxaliplatin, Capecitabine

## Key facts

- **NCT ID:** NCT00266279
- **Lead sponsor:** University of Louisville
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2020-09-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00266279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00266279, "Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck Malignancies". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00266279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*